BACKGROUND: Alcohol consumption has been in existence in the world for many centuries and it is the major cause of death and injury worldwide. Alcoholic liver disease (ALD) is caused due to excess and chronic alcohol intake. Studies across the globe have identified several pathways leading to ALD. Adipose tissue which has been considered as an energy storage organ is also found to play a major role in ALD progression by secreting hormones and cytokines known as adipokines or adipocytokines. Ethanol affects the metabolic and innate immune activities of adipose tissue contributing to alcohol-induced injury of the tissues. OBJECTIVE: We aimed at 1) summarizing the metabolism and progression of ALD 2) summarizing about the structure and effect of ethanol induced oxidative stress on adipose tissue 3) reviewing the available data on the effect of ethanol on adipose tissue mass and adipokine secretion in both rodent models and alcoholic patients. METHODS: The article is summarized based on the original literature and reviews in studying the effect of ethanol on adipose tissue. RESULTS: Studies on alcoholic patients and rodent models has shown that chronic ethanol consumption reduces adipose tissue mass and causes CYP2E1 mediated oxidative stress and inflammation of adipose tissue. Further hyperlipolysis is observed in adipose tissue that leads to excess fatty acid release that gets transported and deposited in the liver resulting in hepatic steatosis. CONCLUSION: Studies show that adipose tissue plays a major role in the progression of ALD. So understanding of the mechanisms linking ethanol induced adipose tissue injury with ALD progression would help us in identifying potential therapeutic targets.
BACKGROUND:Alcohol consumption has been in existence in the world for many centuries and it is the major cause of death and injury worldwide. Alcoholic liver disease (ALD) is caused due to excess and chronic alcohol intake. Studies across the globe have identified several pathways leading to ALD. Adipose tissue which has been considered as an energy storage organ is also found to play a major role in ALD progression by secreting hormones and cytokines known as adipokines or adipocytokines. Ethanol affects the metabolic and innate immune activities of adipose tissue contributing to alcohol-induced injury of the tissues. OBJECTIVE: We aimed at 1) summarizing the metabolism and progression of ALD 2) summarizing about the structure and effect of ethanol induced oxidative stress on adipose tissue 3) reviewing the available data on the effect of ethanol on adipose tissue mass and adipokine secretion in both rodent models and alcoholicpatients. METHODS: The article is summarized based on the original literature and reviews in studying the effect of ethanol on adipose tissue. RESULTS: Studies on alcoholicpatients and rodent models has shown that chronic ethanol consumption reduces adipose tissue mass and causes CYP2E1 mediated oxidative stress and inflammation of adipose tissue. Further hyperlipolysis is observed in adipose tissue that leads to excess fatty acid release that gets transported and deposited in the liver resulting in hepatic steatosis. CONCLUSION: Studies show that adipose tissue plays a major role in the progression of ALD. So understanding of the mechanisms linking ethanol induced adipose tissue injury with ALD progression would help us in identifying potential therapeutic targets.
Authors: Thomas Hillemacher; Christian Weinland; Annemarie Heberlein; Michael Gröschl; Anja Schanze; Helge Frieling; Julia Wilhelm; Johannes Kornhuber; Stefan Bleich Journal: Drug Alcohol Depend Date: 2008-09-24 Impact factor: 4.492
Authors: Li Kang; Xiaocong Chen; Becky M Sebastian; Brian T Pratt; Ilya R Bederman; James C Alexander; Stephen F Previs; Laura E Nagy Journal: J Biol Chem Date: 2007-08-07 Impact factor: 5.157
Authors: Joanne M Ajmo; Xiaomei Liang; Christopher Q Rogers; Brandi Pennock; Min You Journal: Am J Physiol Gastrointest Liver Physiol Date: 2008-08-28 Impact factor: 4.052
Authors: M Krsek; M Rosická; J Nedvídková; H Kvasnicková; V Hána; J Marek; M Haluzík; E W Lai; K Pacák Journal: Physiol Res Date: 2005-10-17 Impact factor: 1.881
Authors: Ashley R DeGroat; Christina K Fleming; Samantha M Dunlay; Kendra L Hagood; Jonathan P Moorman; Jonathan M Peterson Journal: PLoS One Date: 2018-11-07 Impact factor: 3.240
Authors: Rebecca L McCullough; Megan R McMullen; Kyle L Poulsen; Adam Kim; M Edward Medof; Laura E Nagy Journal: Front Immunol Date: 2018-09-20 Impact factor: 7.561